USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
DIAGNOSTICS FOR THE REAL WORLD, LTD
Address:
840 DEL REY AVE
SUNNYVALE, CA
Phone:
(650) 259-5004
URL:
N/A
EIN:
10584612
DUNS:
141057898
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,097,749.00 5
SBIR Phase II $6,191,358.00 5

Award List:

HBV DIPSTICK FOR RESOURCE-LIMITED BLOOD BANKS

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$127,155.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): According to WHO statistics on blood safety, 80 percent of the world's population has access to 20 percent of the world's safe blood supply. However, more than 20 percent (13,000,000 units) of the world blood supply is not tested for the three major… More

HIV DIPSTICK FOR RESORUCE-LIMITED BLOOD BANKS

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$127,155.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): According to WHO statistics on blood safety, 80 percent of the world's population has access to 20 percent of the world's safe blood supply. However, more than 20 percent (13,000,000 units) of the world blood supply is not tested for the three major… More

HCV DIPSTICK FOR RESOURCE-LIMITED BLOOD BANKS

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$127,155.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): According to WHO statistics on blood safety, 80 percent of the world's population has access to 20 percent of the world's safe blood supply. However, more than 20 percent (13,000,000 units) of the world blood supply is not tested for the three major… More

Triplex HIV, HCV and HBV dipstick

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$134,520.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): According to WHO statistics on blood safety, 80 percent of the world's population has access to 20 percent of the world's safe blood supply. However, more than 20 percent (13,000,000 units) of the world blood supply is not tested for the three major transfusion… More

HCV dipstick for resource-limited blood banks

Award Year / Program / Phase:
2005 / SBIR / Phase II
Award Amount:
$688,744.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): According to WHO statistics on blood safety, 80% of the world's population has access to 20% of the world's safe blood supply. However, more than 40% (13,000,000 units) of the blood supply in the developing world is not tested for the three major… More

DRW HIV-Ab/HCV-Ab/HBsAg Triplex Rapid Test Submission for FDA-PMA Approval

Award Year / Program / Phase:
2005 / SBIR / Phase II
Award Amount:
$843,962.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): According to WHO statistics on blood safety, 80% of the world's population has access to 20% of the world's safe blood supply. However, more than 40% (13,000,000 units) of the blood supply in the developing world is not tested for the three major… More

Preclinical and clinical studies of an HBV rapid test for FDA Pre-market approval

Award Year / Program / Phase:
2007 / SBIR / Phase II
Award Amount:
$964,487.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Diagnostics for the Real World, Ltd. (DRW) aims to market a high-performance rapid test for hepatitis B virus (DRW HBsAg Rapid Test) that will be useful as a diagnostic test in the United States and Europe, and as a pre - and post-donation screening test in blood… More

DRW HIV-Ab/HBsAg Duplex Rapid Test submission for FDA-PMA approval

Award Year / Program / Phase:
2008 / SBIR / Phase II
Award Amount:
$1,782,781.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Confidential information: Patent application in process. Diagnostics for the Real World, Ltd. (DRW) aims to market a high-performance duplex rapid test (DRW HIV-Ab/HBsAg Duplex Rapid Test), called DRW HIV-HBV Duplex, wh ich can simultaneously detect antibodies to… More

DRW HIV-Ab/HCV-Ab/HBsAg Triplex Rapid Test Submission for FDA-PMA Approval

Award Year / Program / Phase:
2010 / SBIR / Phase II
Award Amount:
$1,911,384.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Confidential information: patent application in process. Diagnostics for the Real World, Ltd. (DRW) aims to market a high-performance triplex rapid test (DRW HIV- Ab/HCV-Ab/HBsAg Triplex Rapid Test; DRW-HTRT), which can simultaneously detect for anti-HIV… More

SAMBA HIV-1 Semi-quantitative Test for resource limited settings

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$581,764.00
Agency:
HHS
Principal Investigator:
Helen H. Lee – 408-773-1511
Abstract:
DESCRIPTION (provided by applicant): The ultimate aim of this project is to develop a CE-marked and/or FDA-approved diagnostic platform for viral load monitoring of HIV-1 infected patients in point-of-care (POC) and resource- limited settings. Currently available viral load tests are not suitable… More